Abstract-We report here on the clinical, genetic, and molecular characterization of 1 Han Chinese family with maternally transmitted hypertension. Three of 7 matrilineal relatives in this 4-generation family exhibited the variable degree of essential hypertension at the age at onset, ranging from 35 to 60 years old. Sequence analysis of the complete mitochondrial DNA in this pedigree identified the novel homoplasmic 4401AϾG mutation localizing at the spacer immediately to the 5Ј end of tRNA Met and tRNA Gln genes and 39 other variants belonging to the Asian haplogroup C. The 4401AϾG mutation was absent in 242 Han Chinese controls. Approximately 30% reductions in the steady-state levels of tRNA Met and tRNA Gln were observed in 2 lymphoblastoid cell lines carrying the 4401AϾG mutation compared with 2 control cell lines lacking this mutation. Failures in mitochondrial metabolism are apparently a primary contributor to the reduced rate of mitochondrial translation and reductions in the rate of overall respiratory capacity, malate/glutamatepromoted respiration, succinate/glycerol-3-phosphate-promoted respiration, or N,N,NЈ,NЈ-tetramethyl-p-phenylenediamine/ ascorbate-promoted respiration in lymphoblastoid cell lines carrying the 4401AϾG mutation. The homoplasmic form, mild biochemical defect, late onset, and incomplete penetrance of hypertension in this family suggest that the 4401AϾG mutation itself is insufficient to produce a clinical phenotype. Thus, the other modifier factors, eg, nuclear modifier genes and environmental and personal factors, may also contribute to the development of hypertension in these subjects carrying this mutation. These data suggest that mitochondrial dysfunctions, caused by the 4401AϾG mutation, are involved in the development of hypertension in this Chinese pedigree. (Hypertension. 2009;54:00-00.)
C ardiovascular disease is the leading cause of death in America and the world. In particular, hypertension affects Ϸ1 billion individuals worldwide and 130 million in China. 1 The etiology of cardiovascular disease is not well understood because of the multifactorial causes. Cardiovascular disease can be caused by a single gene or multifactorial conditions, resulting from interactions between environment and inherited risk factors. Of hereditary factors, the maternal transmissions of cardiovascular disease have been implicated in some pedigrees, suggesting that the mutation(s) in mitochondrial DNA (mtDNA) is one of the molecular bases for this disorder. [2] [3] [4] [5] [6] Recently, several mtDNA point mutations have been identified to be associated with cardiovascular disease. These mutations included the 1555AϾG mutation in the 12S ribosomal RNA (rRNA) gene, 7 the 3260AϾG and 3303CϾT mutations in the tRNA Leu(UUR) gene, 8, 9 the 8348AϾG and 8363GϾA mutations in the tRNA Lys gene, 10, 11 and the 4295AϾG, 4300AϾG, and 4317AϾG mutations in the tRNA Ile gene. [12] [13] [14] Most recently, the 4291TϾC mutation in tRNA Ile gene has been associated with a cluster of metabolic defects, including essential hypertension, hypercholesterolemia, and hypomagnesemia in a large family. 15 With an effort to understand a role of the mitochondrial genome in the pathogenesis of cardiovascular disease in the Chinese population, we have initiated a systematic and extended mutational screening of mtDNA in a large cohort of hypertension subjects in the Geriatric Cardiology Clinic at the Chinese People's Liberation Army General Hospital. 16 -18 In the present study, we performed the clinical, genetic, and molecular characterizations of another Han Chinese family with maternally transmitted hypertension. Three (2 men/1 woman) of 7 matrilineal relatives in this 4-generation family exhibited the variable severity and age at onset in hypertension. Mutational analysis of the mitochondrial genome has identified the novel 4401AϾG mutation in this Chinese family. This novel 4401AϾG mutation is localized at the junction between the tRNA Met at the heavy strand and tRNA Gln at the light strand. 19, 20 Thus, it is hypothesized that the 4401AϾG mutation affects the processing of precursors in these mitochondrial tRNAs. Functional significance of the 4401AϾG mutation was evaluated by examining for the steady-state levels of mitochondrial tRNA Met , tRNA Gln , and other tRNAs, including tRNA Lys , tRNA Gly , and tRNA Ser -(UCN), using lymphoblastoid cell lines derived from 2 affected matrilineal relatives carrying the 4401AϾG mutation and from 2 married-in-control individuals lacking the mtDNA mutation. These cell lines were further assessed for the effects of the 4401AϾG mutation on the rate of mitochondrial protein synthesis, the endogenous respiration, and substratedependent respiration.
Materials and Methods

Subjects
As a part of genetic screening program for hypertension, a Han Chinese family ( Figure 1) 
Measurements of Blood Pressure
Members of this Chinese family underwent a physical examination, laboratory assessment of cardiovascular disease risk factors, and routine electrocardiography. A physician measured the systolic and diastolic blood pressures of subjects using a mercury column sphygmomanometer and a standard protocol. The first and the fifth Korotkoff sounds were taken as indicative of systolic and diastolic blood pressures, respectively. The average of 3 such systolic and diastolic blood pressure readings was taken as the examination blood pressure. Hypertension was defined according to the recommendation of the Sixth Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure. 21 and the World Health Organization-International Society of Hypertension 22 as a systolic blood pressure of Ն140 mm Hg and/or a diastolic blood pressure of Ն90 mm Hg.
Mutational Analysis of Mitochondrial Genome
Genomic DNA was isolated from whole blood of participants using Puregene DNA Isolation kits (Gentra Systems). The entire mitochondrial genome of the proband II-1 was PCR amplified in 24 overlapping fragments by use of sets of the light-strand and the heavy-strand oligonucleotide primers, as described elsewhere. 23 Each fragment was purified and subsequently analyzed by direct sequencing in an ABI 3700 automated DNA sequencer using the Big Dye Terminator Cycle sequencing reaction kit. The resultant sequence data were compared with the revised Cambridge reference sequence (GenBank accession No. NC001807). 24 For the quantification of the 4401AϾG mutation, the first PCR segments (903 bp) were amplified using genomic DNA as a template and oligodeoxynucleotides corresponding with mtDNA at positions 3777 to 4679 to rule out the coamplification of possible nuclear pseudogenes. 25 Then, the second PCR product (225 bp) was amplified using the first PCR fragment as a template, and oligodeoxynucleotides corresponding with mtDNA at positions 4243 to 4467 and subsequently digested with the restriction enzyme BfaI as the 4401AϾG mutation creates the site for this restriction enzyme. Equal amounts of various digested samples were then analyzed by electrophoresis through 7% polyacrylamide gel. The proportions of digested and undigested PCR products were determined by the Image-Quant program after ethidium bromide staining to determine whether 4401AϾG mutation is in the homoplasmy in these subjects. The allele frequency of the 4401AϾG variant was determined by PCR amplification using the genomic DNA derived from 242 Han Chinese controls and subsequent restriction enzyme analysis of PCR products, as described above.
Mitochondrial tRNA Analysis
Lymphoblastoid cell lines were immortalized by transformation with the Epstein-Barr virus, as described elsewhere. 26 Cell lines derived from 1 proband II-1 and her son III-3 carrying the 4401AϾG mutation and 2 Chinese married-in controls (II-2 and III-4) lacking this mutation were grown in RPMI 1640 (Invitrogen), supplemented with 10% FBS. Total mitochondrial RNA were obtained using a TOTALLY RNA kit (Ambion) from mitochondria isolated from lymphoblastoid cell lines (Ϸ4.0ϫ10 8 cells), as described previously. 27 Two micrograms of total mitochondrial RNA were electrophoresed through a 10% polyacrylamide/7 mol/L urea gel in Tris-borate-EDTA buffer (after heating the sample at 65°C for 10 minutes) and then electroblotted onto a positively charged nylon membrane (Roche) for the hybridization analysis with oligodeoxynucleotide probes. For the detection of tRNA ). 24 DIG-labeled oligodeoxynucleotides were generated by using a DIG Oligonucleotide Tailing Kit (Roche). The hybridization was carried out as detailed elsewhere. 28 Quantification of density in each band was made as detailed previously. 28 -30 
Analysis of Mitochondrial Protein Synthesis
Pulse labeling of the cell lines for 30 minutes with [ ]cysteine in methionine-free DMEM in the presence of emetine, electrophoretic analysis of the translation products, and quantification of radioactivity in the whole-electrophoretic patterns or in individual well-resolved bands was carried out as detailed previously. 31 
O 2 Consumption Measurements
Rates of O 2 consumption in intact cells were determined with a YSI 5300 oxygraph (Yellow Springs Instruments) on samples of 1ϫ10 7 cells in 1.5 mL of special DMEM glucose lacking glucose and supplemented with 10% dialyzed FBS. 32 Polarographic analysis of digitonin-permeabilized cells using different respiratory substrates and inhibitors to test the activity of the various respiratory complexes was carried out as detailed previously. 33
Results
Clinical Presentation
The proband (II-1) began suffering from hypertension at the age of 60 years. She came to the Geriatric Cardiology Clinic of the Chinese People's Liberation Army General Hospital for further clinical evaluations at the age of 65 years. Her blood pressure was 180/110 mm Hg. Physical examination, laboratory assessment of cardiovascular disease risk factors, and routine electrocardiography showed no other clinical abnormalities, including diabetes mellitus, vision and hearing impairments, or renal and neurological disorders. Therefore, she exhibited a typical essential hypertension. The family originated from Beijing in northern China, and the majority of family members live in the same area. As shown in Figure 1 , this familial history is consistent with a maternal inheritance. None of the offspring of affected fathers had hypertension. Two male matrilineal relatives exhibited hypertension as the sole clinical symptom, whereas other members of this family had normal blood pressure. As shown in Table 1 , subject III-3 experienced the hypertension (blood pressure was 140/ 110 mm Hg) at the age of 36 years, whereas his brother (III-5) had hypertension (blood pressure was 140/95 mm Hg) at the age of 35 years. There is no evidence that any member of this family had any other known cause to account for hypertension. Comprehensive family medical histories of these individuals showed no other clinical abnormalities, including diabetes mellitus, vision and hearing impairments, or renal and neurological disorders.
Mitochondrial DNA Analysis
The maternal transmission of hypertension in this family suggested the mitochondrial involvement and led us to analyze the mitochondrial genome of matrilineal relatives. For this purpose, the DNA fragments spanning the entire mtDNA of the proband II-1 were PCR amplified, and each fragment was purified and subsequently analyzed by direct sequence. As shown in Table 2 , the comparison of the resultant sequences with the Cambridge consensus sequence identified a number of nucleoside changes, belonging to the Eastern Asian haplogroup C. 34 Of these nucleoside changes, 35 These missense mutations are 5262GϾA (264AϾT) in the ND2 gene, 8584GϾA (20AϾT), 8701AϾG (59TϾA), and 8860AϾG (112TϾA) in the ATP6 gene, 10398AϾG (114TϾA) in the ND3 gene, 11447GϾA (230VϾM) in the ND4 gene, 14318TϾC (119NϾS) in the ND6 gene, and 15326AϾG (194TϾA) in the Cytb gene. These variants in rRNAs and polypeptides were further evaluated by phylogenetic analysis of these variants and sequences from other organisms, including mouse, 36 bovine, 37 and Xenopus laevis. 38 None of variants in the polypeptides and rRNAs were highly evolutionarily conserved and implicated to have significantly functional consequence.
However, the novel A to G transition at the position 4401 (4401AϾG) mutation, as shown in Figure 2 , lies at the junction of tRNA Met at the H-strand and tRNA Gln at the L-strand. 19, 20 Here the 5Ј end of the flanking sequence is 4401A/AGTAAG in the tRNA Met gene, whereas the 5Ј end of the flanking sequence is 4401T/TGAGAT in the tRNA Gln gene. 39 In fact, the processing of mitochondrial tRNAs requires the precise endonucleolytic cleavage at both 3Ј and 5Ј ends catalyzed by RNase P and 3Ј endonuclease. 20, 40, 41 Thus, the 4401AϾG mutation may affect the reaction efficiency of the RNase P involved in tRNA Met and tRNA Gln 5Ј end metabolism. The 4401AϾG mutation was further assessed by phylogenetic analysis of this variant and sequences from mouse, bovine, and X laevis, as well as other 13 primates including Gorilla gorilla, Pan paniscus, Pan troglodytes, Pongo pygmaeus, Pongo abelii, Hylobates lar, Macaca mulatta, Macaca sylvanus, Papio hamadryas, Cebus albifrons, Tarsius bancanus, Nycticebus coucang, and Lemur catta (Genbank). In fact, the adenine at the 4401 position is extraordinarily conserved among these species. To determine whether the 4401AϾG mutation is present in homoplasmy, the fragments spanning the tRNA Met and tRNA Gln genes were PCR amplified and subsequently digested with BfaI, because the 4401AϾG mutation creates the site for this restriction enzyme. As shown in Figure 2C , there was no detectable wild-type DNA in 4 matrilineal relatives, indicating that the 4401AϾG mutation was present in homoplasmy in these matrilineal relatives. In addition, this mutation was absent in 242 Han Chinese controls.
Mitochondrial tRNA Analysis
To examine whether the 4401AϾG mutation affects the processing of the precursors in the tRNA Met and tRNA Gln , the steady-state levels of the tRNA Met and tRNA Gln were determined by isolating total mitochondrial RNA from cell lines derived from 2 affected individuals (II-1 and III-3) carrying the 4401AϾG mutation and 2 married-in controls (II-2 and III-4) lacking this mutation in this Chinese family, separating them by a 10% polyacrylamide/7 mol/L urea gel, electroblotting, and hybridizing with a nonradioactive DIG-labeled oligodeoxynucleotide probe specific for tRNA Met and tRNA
Gln
. After stripping the blots, the DIG-labeled oligodeoxynucleotide probes, 39 Processing sites in the mitochondrial tRNA Met and tRNA Gln precursors were determined for RNase P. 40 Arrow indicates the position of the 4401AϾG mutation. C, Quantification of the mtDNA 4401AϾG mutation in 8 members of the Chinese family. PCR products around the 4401AϾG mutation were digested with BfaI and analyzed by electrophoresis in a 7% polyacrymide gel stained with ethidium bromide. Patients and control individuals are indicated.
including tRNA
Gly and tRNA Lys as representatives of the whole H-strand transcription unit and tRNA Ser(UCN) derived from the L-strand transcription unit, 19, 20 were hybridized with the same blots for normalization purposes.
As shown in Figure 3A , the amounts of tRNA Met and tRNA Gln in mutant cells were markedly decreased as compared with those in control cells. For comparison, the average levels of tRNA Met and tRNA Gln in various control or mutant cell lines were normalized to the average levels in the same cell line for the tRNA Gly , tRNA Lys , and tRNA Ser(UCN) , respectively. As shown in Figure 3B , the levels of tRNA Met and tRNA Gln in the mutant cells were significantly reduced relative to the controls. In particular, the average levels of tRNA Met in the mutant cell lines derived from II-1 and III-3 ranged from Ϸ71% of controls after normalization to tRNA Gly , Ϸ67% of controls after normalization to tRNA Lys , to Ϸ70% of controls after normalization to tRNA Ser(UCN) . Similarly, the average levels of tRNA Gln in the mutant cell lines derived from II-1 and III-3 ranged from Ϸ75% of controls after normalization to tRNA Gly , Ϸ71% of controls after normalization to tRNA Lys , to Ϸ70% of controls after normalization to tRNA Ser(UCN) .
Mitochondrial Protein Synthesis Defect
To examine whether a defect in mitochondrial translation occurred in lymphoblastoid cell lines carrying the 4401AϾG mutation, cells derived from 2 affected individuals (II-1 and III-3) carrying the 4401AϾG mutation and 2 married-in controls (II-2 and III-4) lacking this mutation in this Chinese family were labeled for 30 minutes with [ 35 S]methionine-[ 35 S]cysteine in methionine-free regular DMEM in the presence of 100 g/mL of emetine to inhibit cytosolic protein synthesis. 31 Figure 4A shows typical electrophoretic patterns of the mitochondrial translation products of the mutant and control cell lines. Patterns of the mtDNA-encoded polypeptides of the cells carrying the 4401AϾG mutation were qualitatively identical in terms of electrophoretic mobility of the various polypeptides to those of the control cells and of 143B.TK Ϫ cells. However, the cell lines carrying the 4401AϾG mutation showed a clear tendency toward a decrease in the total rate of labeling of the mitochondrial translation products relative to those of control cell lines. Figure 4B shows a quantification of the results of a large number of labeling experiments and electrophoretic runs, which were carried out by the Image-Quant program of appropriate exposures of the fluorograms and normalization to data obtained for the 143B.TK Ϫ sample. In fact, the overall rates of labeling of the mitochondrial translation products in the cell lines derived from 2 affected individuals (II-1 and III-3) carrying the 4401AϾG mutation were decreased 31.7% and 20.8%, with an average of 26.0% relative to the mean value measured in the control cell lines.
Respiration Defects in the Cell Lines
The endogenous respiration rates of cell lines derived from 2 affected individuals (II-1 and III-3) carrying the 4401AϾG mutation and 2 married-in controls (II-2 and III-4) lacking this mutation in this Chinese family were measured by determining the O 2 consumption rate in intact cells, as described previously. 32 As shown in Figure 5A , the rate of total O 2 consumption in the lymphoblastoid cell lines derived from 2 affected individuals (II-1 and III-3) ranged between ϳ74.9% and 80.6%, with an average reduction of ϳ77.8% relative to the mean value measured in the control cell lines.
To investigate which of the enzyme complexes of the respiratory chain was affected in the mutant cell lines, O 2 consumption measurements were carried out on digitoninpermeabilized cells using different substrates and inhibitors. 33 As shown in Figure 5B , in the cell lines derived from 2 affected individuals, the rate of malate/glutamate-driven res- 
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piration, which depends on the activities of reduced nicotinamide-adenine dinucleotide:ubiquinone oxidoreductase (complex I), ubiquinol-cytochrome c reductase (complex III), and cytochrome c oxidase (complex IV), but usually reflects the rate-limiting activity of complex I, 33 was very significantly decreased, relative to the average rate in the control cell lines, by 77% to 80% (ϳ78% on average). Similarly, the rate of succinate/glycerol-3-phosphate-driven respiration, which depends on the activities of complexes III and IV but usually reflects the rate-limiting activity of complex III, was significantly affected in the mutant cell lines, relative to the average rate in the control cell lines, by 76% to 81% (ϳ78% on average). Furthermore, the rate of N,N,NЈ,NЈ-tetramethyl-p-phenylenediamine/ascorbate-driven respiration, which reflects the activity of complex IV, exhibited a 78% to 82% reduction in complex IV activity (ϳ80% on average) in the mutant cell lines relative to the average rate in the control cell lines.
Discussion
In the present study, we performed the clinical, genetic, and molecular characterization of a Han Chinese family with essential hypertension. The hypertension as a sole clinical phenotype was only present in all of the matrilineal relatives of this 4-generation pedigree. Clinical and genetic evaluations revealed the variable severity and age at onset in hypertension among 3 of 7 matrilineal relatives in this Chinese family. In particular, the age at onset in hypertension was 60, 36, and 35 years in 3 affected matrilineal relatives, with an average age of 44 years. The maternal transmission of hypertension in this family suggested that the mtDNA mutation(s) is 1 of the molecular bases for this disorder. Mutational analysis of the mitochondrial genome in this family identified 40 variants belonging to the Eastern Asian haplogroup C. 34 Of these, 39 variants appeared to be polymorphisms, because these variants were not highly evolutionarily conserved and implicated to have significantly functional consequence. However, the homoplasmic A-to-G transition at position 4401 lies in the spacer immediately to the 5Ј end of the tRNA Met and tRNA Gln genes. 19, 24 Furthermore, the adenine at the 4401 position of the mitochondrial genomes is highly conserved among various primates. This mutation is present only in matrilineal relatives of this family in the homoplasmic form but not in the 242 Han Chinese controls, indicating that this mutation may be involved in the pathogenesis of hypertension. In fact, 22 human mitochondrial tRNAs are interspersed among the other functional mitochondrial RNAs (2 rRNAs and 11 mRNAs encoding 13 polypeptide subunits of the oxidative phosphorylation complexes) on long precursor transcripts. 19 Of these, 8 tRNAs, including tRNA Gln and tRNA Ser(UCN) , are synthesized from the polycistronic precursors of the L-strand, whereas the other 14 tRNAs, eg, tRNA Met , tRNA Lys , and tRNA Gly , are transcribed from the precursors of the H-strand transcripts. 19, 42 The processing of precursors in mitochondrial tRNAs requires the precise endonucleolytic cleavage at both 5Ј and 3Ј ends. Extra nucleotides at their 5Ј termini are removed by RNase P, whereas the excision of tRNAs from primary polycistronic mitochondrial transcripts at their 3Ј end is catalyzed by the 3Ј endonuclease. 19, 43 Thus, it is anticipated that the A-to-G transition at position 4401 in the H-strand may lead to defective tRNA Met 5Ј end processing in the H-strand transcripts, and the T-to-C transition at position 4401 may cause the reduced efficiency of the tRNA Gln precursor 5Ј end cleavage in the L-strand transcripts. There is increasing evidence showing that the 5Ј and 3Ј end processing defects arising from pathogenic mitochondrial tRNA mutations could contribute to clinical abnormalities. The deafness-associated 7445TϾC mutation in the precursor of the tRNA Ser(UCN) gene and the cardiomyopathies-associated 4269AϾG and 4295AϾG mutations in the tRNA Ile gene altered 3Ј end processing efficiency of corresponding tRNAs. 41, 44 Similarly, the mitochondrial encephalomyopathy, lactic acidosis, stroke-like symptoms (MELAS)-associated 3243AϾG and 3271TϾC mutations and mitochondrial myopathy-associated 3302AϾG mutation in the tRNA Leu(UUR) led to the tRNA 5Ј end processing defects. 45, 46 Alternatively, a taurine modification deficiency at the anticodon wobble position of tRNA Leu(UUR) carrying the 3243AϾG or 3271TϾC mutation is involved in the decreased translation of ND6 with a high content of the UUG codon. 47 In the current study, compared with a control cell lacking the mutation, a Ϸ30% reduction in the levels of tRNA Met and tRNA Gln were observed in cells carrying the 4401AϾG mutation. The lower levels of tRNA Met and tRNA Gln in cells carrying the 4401AϾG mutation most probably result from a defect in the 5Ј end processing of tRNA Met and tRNA Gln precursors. As a result, a shortage of the tRNA Met and tRNA Gln leads to the reduced rate of mitochondrial protein synthesis. These defects appear to be responsible for the reduced activities of the mitochondrial respiration chain. Subsequently, these defects lead to the reduction of ATP production and an increase of reactive oxygen species production. These mitochondrial dysfunctions likely contribute to the development of hypertension. 48 -50 However, the levels of total tRNA Met and tRNA Gln in mutant cells are above a proposed threshold, which is 30% of the control level of tRNA, to support a normal rate of mitochondrial translation. 20, 28 Thus, the homoplasmic form, mild mitochondrial dysfunctions, late onset, and incomplete penetrance of hypertension in this family carrying the 4401AϾG mutation indicated that the 4401AϾG mutation itself is insufficient to produce a clinical phenotype, as in the cases of hypertensionassociated tRNA Met 4435AϾG mutation, 18 deafnessassociated 12S rRNA 1555AϾG mutation, 51, 52 and Leber's hereditary optic neuropathy-associated ND4 11778GϾA mutation. 53 The other modifier factors, eg, nuclear modifier genes, environmental factors, and personal lifestyles, also contribute to the development of hypertension in these subjects carrying the 4401AϾG mutation. Therefore, the 4401AϾG mutation, acting as an inherited risk factor, is involved in the development of hypertension in this Chinese family. 
Perspectives
The genetic and biochemical evidence indicate that the mtDNA 4401AϾG mutation is involved in essential hypertension. The tissue specificity of this pathogenic mtDNA mutation is likely attributed to tissue-specific RNA processing or the involvement of nuclear modifier genes. The 4401AϾG mutation should be added to the list of inherited risk factors for future molecular diagnosis for hypertension. Thus, our finding will provide new insights into the molecular mechanism, management, and treatment of maternally inherited hypertension. Future research should further explore the emerging link among hypertension, mitochondrial dysfunction, and their causative-effect relationship. 
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